Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.55NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.51NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.51NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.308NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.308NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.138NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.138NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.379NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.379NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.240NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.240NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.240.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.240.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.121.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.121.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.1.46NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.46NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.44NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.236NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.236NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.153NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.153NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.302NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.302NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.194NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.194NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.436NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.436NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.558NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.558NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.518NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.518NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.368NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.368NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.404NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.404NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
AZ.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.436ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.436ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.558ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used